{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T10:30:02Z","timestamp":1788604202182,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.cpcardiol.2022.101154","type":"journal-article","created":{"date-parts":[[2022,2,19]],"date-time":"2022-02-19T18:09:11Z","timestamp":1645294151000},"page":"101154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Review of Functional Status and Hemodynamic Parameters in Patients Diagnosed with Chronic Thromboembolic Pulmonary Hypertension (CTEPH) With and Without Antiphospholipid Syndrome (APLS)"],"prefix":"10.1016","volume":"48","author":[{"given":"David","family":"Puebla-Aldama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Cueto-Robledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda-del-Pilar","family":"Barragan-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Roldan-Valadez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dulce-Iliana","family":"Navarro-Vergara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisol","family":"Garcia-Cesar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla-Liliana","family":"Heredia-Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Berenice","family":"Torres-Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos-Felipe","family":"Garcia-Treminio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector Daniel","family":"Cueto-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2022.101154_bib0001","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s11739-018-02021-z","article-title":"Prevalence of antiphospholipid (aPL) antibodies among patients with chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis","volume":"14","author":"Cheng","year":"2019","journal-title":"Intern Emerg Med [Internet]"},{"key":"10.1016\/j.cpcardiol.2022.101154_bib0002","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1055\/s-0039-1683994","article-title":"Lung disease in antiphospholipid syndrome","volume":"40","author":"Maioli","year":"2019","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.cpcardiol.2022.101154_bib0003","doi-asserted-by":"crossref","first-page":"S201","DOI":"10.1513\/AnnalsATS.201509-621AS","article-title":"Chronic thromboembolic pulmonary hypertension: Epidemiology and risk factors","volume":"13","author":"Delcroix","year":"2016","journal-title":"Ann Am Thorac Soc"},{"issue":"9","key":"10.1016\/j.cpcardiol.2022.101154_bib0004","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1055\/s-0039-1692428","article-title":"Antiphospholipid syndrome in chronic thromboembolic pulmonary hypertension: A well-defined subgroup of patients","volume":"119","author":"Jiang","year":"2019","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cpcardiol.2022.101154_bib0005","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1160\/TH13-07-0538","article-title":"Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Prevalence of CTEPH after pulmonary embolism","volume":"112","author":"Gu\u00e9rin","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cpcardiol.2022.101154_bib0006","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1161\/CIRCULATIONAHA.110.015008","article-title":"Chronic thromboembolic pulmonary hypertension (CTEPH): Results from an international prospective registry","volume":"124","author":"Pepke-Zaba","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2022.101154_bib0007","first-page":"1927","article-title":"Incidence and risk factors of chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism","volume":"7","author":"Yang","year":"2015","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.cpcardiol.2022.101154_bib0008","first-page":"1","article-title":"Chronic thromboembolic pulmonary hypertension","volume":"53","author":"Kim","year":"2019","journal-title":"Eur Respir J [Internet]"},{"key":"10.1016\/j.cpcardiol.2022.101154_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13019-020-01254-4","article-title":"Antiphospholipid syndrome with chronic thromboembolic pulmonary hypertension and coronary artery disease: A case report","volume":"15","author":"Sugiyama","year":"2020","journal-title":"J Cardiothorac Surg"},{"key":"10.1016\/j.cpcardiol.2022.101154_bib0010","doi-asserted-by":"crossref","first-page":"163","DOI":"10.5582\/irdr.2017.01044","article-title":"Pulmonary hypertension associated with antiphospholipid antibody: Call for a screening tool?","volume":"6","author":"Parthvi","year":"2017","journal-title":"Intractable Rare Dis Res"},{"key":"10.1016\/j.cpcardiol.2022.101154_bib0011","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S0049-3848(17)30066-X","article-title":"Antiphospholipid syndrome","volume":"151","author":"Cervera","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.cpcardiol.2022.101154_bib0012","doi-asserted-by":"crossref","first-page":"m2177","DOI":"10.1136\/bmj.m2177","article-title":"Pulmonary embolism: update on management and controversies","volume":"370","author":"Duffett","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.cpcardiol.2022.101154_bib0013","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: A multicentre prospective study of 1000 patients","volume":"74","author":"Cervera","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cpcardiol.2022.101154_bib0014","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1177\/0961203309106832","article-title":"The Euro-Phospholipid project: Epidemiology of the antiphospholipid syndrome in Europe","volume":"18","author":"Cervera","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.cpcardiol.2022.101154_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biomedicines8110508","article-title":"Management of antiphospholipid syndrome","volume":"8","author":"Ghembaza","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.cpcardiol.2022.101154_bib0016","first-page":"1","article-title":"Antiphospholipid syndrome","volume":"34","author":"Sammaritano","year":"2020","journal-title":"Best Pract Res Clin Rheumatol [Internet]"},{"key":"10.1016\/j.cpcardiol.2022.101154_bib0017","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.trsl.2020.04.006","article-title":"Antiphospholipid syndrome","volume":"225","author":"Petri","year":"2020","journal-title":"Transl Res [Internet]"},{"issue":"4","key":"10.1016\/j.cpcardiol.2022.101154_bib0018","first-page":"1","article-title":"Antiphospholipid syndrome","volume":"11","author":"Schreiber","year":"2018","journal-title":"Nat Rev Dis Prim"},{"issue":"1","key":"10.1016\/j.cpcardiol.2022.101154_bib0019","doi-asserted-by":"crossref","DOI":"10.1007\/s11926-014-0478-8","article-title":"Pulmonary Hypertension in Antiphospholipid Syndrome","volume":"17","author":"Zuily","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.cpcardiol.2022.101154_bib0020","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1177\/0961203318810427","article-title":"Pulmonary thromboendarterectomy is a curative resolution for chronic thromboembolic pulmonary hypertension associated with antiphospholipid syndrome: a retrospective cohort study","volume":"27","author":"Li","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.cpcardiol.2022.101154_bib0021","first-page":"225","article-title":"Chronic thromboembolic pulmonary hypertension with and without antiphospholipid syndrome","volume":"67","author":"Colorio","year":"2007","journal-title":"Med (Buenos Aires)"},{"key":"10.1016\/j.cpcardiol.2022.101154_bib0022","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/jth.13175","article-title":"Derivation of a clinical prediction score for chronic thromboembolic pulmonary hypertension after acute pulmonary embolism","volume":"14","author":"Klok","year":"2016","journal-title":"J Thromb Haemost"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280622000512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280622000512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T02:25:08Z","timestamp":1758939908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280622000512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0146280622000512"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2022.101154","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review of Functional Status and Hemodynamic Parameters in Patients Diagnosed with Chronic Thromboembolic Pulmonary Hypertension (CTEPH) With and Without Antiphospholipid Syndrome (APLS)","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2022.101154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"101154"}}